Growth Metrics

Stereotaxis (STXS) Gross Margin (2010 - 2026)

Stereotaxis (STXS) reported Gross Margin of 60.31% for Q1 2026, up 592.0% year-over-year from 8.72% in Q1 2025, and up 20.45% on a QoQ basis from 50.07% in Q4 2025.

Stereotaxis (STXS) has 17 years of Gross Margin data on file, last reported at 60.31% in Q1 2026.

  • Quarterly Gross Margin rose 592.0% year-over-year to 60.31% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 53.86% (up 45.0% YoY) and the FY2025 annual result came in at 52.73%, down 149.0% from the prior year.
  • Gross Margin climbed to 60.31% in Q1 2026 per STXS's latest filing, from 50.07% in the prior quarter.
  • Across five years, Gross Margin topped out at 75.91% in Q2 2022 and bottomed at 44.57% in Q3 2024.
  • The 5-year median for Gross Margin is 57.65% (2024), against an average of 58.08%.
  • The widest annual swing landed in 2023, when Gross Margin plunged 2263 bps; it then surged 2031 bps in 2024.
  • Tracing STXS's Gross Margin over 5 years: stood at 59.02% in 2022, then grew by 2 bps to 59.98% in 2023, then retreated by 15 bps to 50.73% in 2024, then fell by 1 bps to 50.07% in 2025, then gained by 20 bps to 60.31% in 2026.
  • Per Business Quant, the three latest STXS Gross Margin figures stand at 60.31% (Q1 2026), 50.07% (Q4 2025), and 54.94% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn 66.06%
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn 45.69%
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 62.25%
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 35.08%
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn 54.66%
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 67.88%
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 70.82%
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn 32.99%
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 35.80%
10 Stereotaxis 187.40 Mn 172.78 Mn 3.79 Mn 60.31%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 60.31%
Dec 31, 2025 50.07%
Sep 30, 2025 54.94%
Jun 30, 2025 52.05%
Mar 31, 2025 54.39%
Dec 31, 2024 50.73%
Sep 30, 2024 44.57%
Jun 30, 2024 73.59%
Mar 31, 2024 57.65%
Dec 31, 2023 59.98%
Sep 30, 2023 52.05%
Jun 30, 2023 53.28%
Mar 31, 2023 59.19%
Dec 31, 2022 59.02%
Sep 30, 2022 59.64%
Jun 30, 2022 75.91%
Mar 31, 2022 69.97%
Dec 31, 2021 72.20%
Sep 30, 2021 51.99%
Jun 30, 2021 72.17%
Mar 31, 2021 69.77%
Dec 31, 2020 76.52%
Sep 30, 2020 53.75%
Jun 30, 2020 79.70%
Mar 31, 2020 83.47%
Dec 31, 2019 74.68%
Sep 30, 2019 77.67%
Jun 30, 2019 83.12%
Mar 31, 2019 79.86%
Dec 31, 2018 80.33%
Sep 30, 2018 78.38%
Jun 30, 2018 81.61%
Mar 31, 2018 81.85%
Dec 31, 2017 28.87%
Sep 30, 2017 76.41%
Jun 30, 2017 73.99%
Mar 31, 2017 81.99%
Dec 31, 2016 72.64%
Sep 30, 2016 72.95%
Jun 30, 2016 86.09%
Mar 31, 2016 74.78%
Dec 31, 2015 73.73%
Sep 30, 2015 73.62%
Jun 30, 2015 69.54%
Mar 31, 2015 72.40%
Dec 31, 2014 76.61%
Sep 30, 2014 73.59%
Jun 30, 2014 75.34%
Mar 31, 2014 80.62%
Dec 31, 2013 68.71%
Sep 30, 2013 67.66%
Jun 30, 2013 74.60%
Mar 31, 2013 73.92%
Dec 31, 2012 65.00%
Sep 30, 2012 69.84%
Jun 30, 2012 68.99%
Mar 31, 2012 69.37%
Dec 31, 2011 -209.05%
Sep 30, 2011 68.90%
Jun 30, 2011 122.93%
Mar 31, 2011 70.61%
Dec 31, 2010 73.44%
Sep 30, 2010 72.21%
Jun 30, 2010 67.20%